Toshiyuki Matsuno

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignees: Zenyaku Kogyo Kabushiki Kaisha, Sony Corporation. Active years: 1992-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyuki Matsuno. Retrieved from https://idiyas.com/inventor/toshiyuki-matsuno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 46.7

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 207(Granted Patents)

Location History:

Saitama, JP (1992)
Ohizumi-machi, JP (2003)
Tokyo, JP (2001 - 2015)

Company Filing History:

14 out of 41

Zenyaku Kogyo Kabushiki Kaisha

Years Active: 1992-2015

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9132130 - Purine derivative and antitumor agent using same (2015-09-15),

2. 9089561 - Methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compounds (2015-07-28),

3. 8563715 - Pyrimidine derivative having cell protecting effect and uses thereof (2013-10-22),

4. 8338414 - Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient (2012-12-25),

5. 7901822 - Fuel cell and voltage supply method (2011-03-08),

6. 7855199 - Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient (2010-12-21),

7. 7767824 - Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient (2010-08-03),

8. 7750001 - Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient (2010-07-06),

9. 7307077 - Heterocyclic compound and antitumor agent containing the same as effective ingredient (2007-12-11),

10. 7153853 - Heterocyclic compounds and antitumor drugs containing the same as the active ingredient (2006-12-26),

11. 7141579 - Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient (2006-11-28),

12. 7071189 - Heterocyclic compound and antitumor agent containing the same as active ingredient (2006-07-04),

13. 6635652 - Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient (2003-10-21),

14. 6251900 - Heterocyclic compounds and antitumor agent containing the same as active ingredient (2001-06-26),

15. 5112833 - 1-azaindolizine derivatives, synthetic intermediates thereof and (1992-05-12),

Title: The Innovative Contributions of Toshiyuki Matsuno

Introduction

Toshiyuki Matsuno is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 15 patents to his name, Matsuno's work has had a considerable impact on the treatment of various health conditions.

Latest Patents

Matsuno's latest patents include a purine derivative and an antitumor agent utilizing the same. This patent discloses a novel purine derivative, a composition thereof, and a method for treating tumors using this purine derivative. Specifically, it details a compound represented by a specific formula, along with its pharmaceutically acceptable salts, solvates, or hydrates. Another significant patent focuses on methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compounds. This patent presents an antidepressant, neuroprotectant, amyloid β deposition inhibitor, or age retardant composition containing a heterocyclic compound with a defined general formula.

Career Highlights

Throughout his career, Matsuno has worked with notable companies such as Zenyaku Kogyo Kabushiki Kaisha and Sony Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Matsuno has collaborated with esteemed colleagues, including Seiichiro Kawashima and Shinichi Yaguchi. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Toshiyuki Matsuno's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new treatments for various medical conditions.

Profile summary based on public USPTO records.